Ibrutinib Medication Guide: Detailed explanation of correct usage and dosage

Ibrutinib, an innovative drug jointly developed byJanssen Biotech, Inc. and Pharmacyclics LLC (AbbVie), has brought new treatment hope to patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenstrom's macroglobulinemia (WM) and chronic graft-versus-host disease (cGVHD) worldwide. In order to ensure that patients can fully enjoy the therapeutic benefits of ibrutinib, this article will introduce in detail the correct usage and dosage of the drug.

1. Drug dosage forms and administration methods

Ibrutinib is an oral capsule. When taking it, swallow it whole. Do not crush, chew or open it. Each time you take it, you should dissolve the medicine completely in a full glass of water and drink it to help the medicine be quickly and fully absorbed by the body. While taking the medication, patients should maintain adequate fluid intake to relieve possible discomfort.

2. Dosage and frequency of administration

The dose and frequency of ibrutinib vary depending on the type of disease and the age of the patient. For adult patients with CLL/SLL and WM, the recommended dose is 420 mg once daily. For patients 12 years and older with cGVHD, the dose is also 420 mg once daily. For patients aged 1 to 12 years old, the dose needs to be calculated based on body surface area, usually 240 mg/m², once daily (the maximum dose does not exceed 420 mg).

Patients are requested to strictly follow the dosage and frequency of medication prescribed by the doctor to ensure that the drug maintains a stable concentration in the body and achieves the best therapeutic effect.

3. Missed dose and make-up dose

If the patient accidentally misses a dose while taking the medicine, he or she can take it as soon as he remembers. But be careful, never take two doses on the same day to avoid overdose. At the same time, patients should adhere to a once-daily medication schedule to ensure stable drug efficacy.

4. Precautions

While taking ibrutinib, patients should pay close attention to their own reactions and consult their doctor promptly if they have any discomfort or questions. In addition, patients should follow their doctor's dietary recommendations and avoid foods or drinks that may interact with their medications.

In short, as an efficient and safe therapeutic drug, ibrutinib’s correct usage and dosage are crucial to the patient’s therapeutic effect. Patients are requested to follow medical instructions to ensure the safety and effectiveness of medication use. Currently, there are multiple versions of ibrutinib available. Patients are asked to make a reasonable choice based on their own needs and economic conditions.